A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis.

Trial Profile

A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical and Anti-Microbial Efficacy and Safety of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone in the Treatment of Subjects With Blepharoconjunctivitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2012

At a glance

  • Drugs Azithromycin/dexamethasone (Primary) ; Azithromycin; Dexamethasone
  • Indications Bacterial infections; Infectious blepharoconjunctivitis
  • Focus Registrational; Therapeutic Use
  • Sponsors InSite Vision
  • Most Recent Events

    • 09 Dec 2008 Primary endpoint 'Resolution of symptoms' has not been met; preliminary results reported in an InSite Vision media release.
    • 03 Oct 2008 Status changed from recruiting to active, no longer recruiting.
    • 27 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top